Monday 30 January 2017

Drugs firms profiteer from NHS by hiking cancer drugs prices

Drug companies are profiteering from the NHS to the tune of £1 billion because they have unjustifiably hiked prices of cancer medicine, experts warn.

from Halifax Courier News Feed http://ift.tt/2kLLoD6
via Telephone Engineers Halifax

No comments:

Post a Comment